Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Canalicular ectonucleoside NTPDase responsible for the main hepatic NTPDase activity. Additionally we are shipping Ectonucleoside Triphosphate diphosphohydrolase 1 Kits (15) and Ectonucleoside Triphosphate diphosphohydrolase 1 Proteins (15) and many more products for this protein.
Showing 10 out of 220 products:
Human Monoclonal ENTPD1 Primary Antibody for FACS, IP - ABIN610072
Estival, Monzat, Miquel, Gaubert, Hollande, Korc, Vaysse, Clemente: Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability. in The Journal of biological chemistry 1996
Show all 4 Pubmed References
Human Monoclonal ENTPD1 Primary Antibody for FACS, IP - ABIN610073
Fox, Shanley: Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. in The Journal of biological chemistry 1996
Show all 4 Pubmed References
Horse (Equine) Polyclonal ENTPD1 Primary Antibody for ICC, IF - ABIN4292709
Hayes, Cairns, Levashova, Chinn, Perez, Theunissen, Liao-Chan, Bermudez, Flory, Schweighofer, H van der Horst: CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma. in American journal of translational research 2015
Show all 4 Pubmed References
Human Monoclonal ENTPD1 Primary Antibody for - ABIN786711
Dahlenborg, Pound, Gordon, Borrebaeck, Carlsson: Signals sustaining human immunoglobulin V gene hypermutation in isolated germinal centre B cells. in Immunology 2000
Mouse (Murine) Monoclonal ENTPD1 Primary Antibody for FACS - ABIN2480161
Dwyer, Deaglio, Gao, Friedman, Strom, Robson: CD39 and control of cellular immune responses. in Purinergic signalling 2008
Mouse (Murine) Monoclonal ENTPD1 Primary Antibody for CyTOF, FACS - ABIN4900313
Yu, Robson, Hill: Expression and distribution of ectonucleotidases in mouse urinary bladder. in PLoS ONE 2011
Extracellular ATP hydrolysis via NTPDase1 action inhibits synaptic transmission by pannexin 1 (show PANX1 Antibodies)-mediated increase in pH buffering of the synaptic cleft.
The peripheral blood mononuclear cells (PBMC) from the transgenic pigs were more resistant to lysis by pooled complement-preserved normal human serum than that from wild type (WT) pig. Accordingly, GGTA1 mutated piglets expressing hCD39 will provide a new organ source for xenotransplantation research
Phosphoantigens (pAgs) induced expression of the ecto-ATPase CD39, which, however, not only hydrolyzed ATP but also abrogated the gammadelta T cell receptor (TCR) agonistic activity of self and microbial pAgs.
These studies showed that the G allele of rs3176891 marks a haplotype associated with increased clotting and platelet aggregation attributable to a promoter variant associated with increased transcription, expression, and activity of NTPDase1.
Transgenic expression of human CD39 is associated with increased renal fibrosis after ischemia in mice.
CD39 overexpression protects against cerebral ischemia in a transgenic mouse model.
Ablation of CD73 minimally effects in vivo thrombosis, but increased CD39 expression on hematopoietic-derived cells, especially monocytes, attenuates in vivo arterial thrombosis.
Data show that Th17(CD39+) cells are markedly diminished and fail to generate AMP (show APRT Antibodies)/adenosine, thereby limiting control of both target cell proliferation and IL-17 (show IL17A Antibodies) production in juvenile autoimmune liver disease (AILD).
concluded that CD39 and CD73 are molecular targets for the development of drugs for ALF (show GTF2A1L Antibodies) patients care
Oxidized low density lipoproteins modulate CD39 and CD73 activity in the endothelium.
this study shows that T-cell expression of CD39 was higher in acute exacerbations of chronic obstructive pulmonary disease patients than stable COPD (show ARCN1 Antibodies) patients or healthy controls
complete deletion of Cd39 paradoxically attenuates development of atherosclerosis in hyperlipidemic mice
Deletion of CD39 and CD73 or both caused an inhibition of the microglia ramified phenotype in the brain with a reduction in the length of processes, branching frequency and number of intersections with Sholl spheres. In vitro, unlike wild-type microglia, cd39-/- and cd73-/- microglial cells were less complex and did not respond to ATP with the transformation into a more ramified phenotype.
CD39 expression by Th17 cells allows the depletion of ATP and is crucial for IL-10 (show IL10 Antibodies) production and survival during the resolution of intestinal inflammation.
Cardiac-specific expression of CD39 reduces myocardial dysfunction and infarct size following ischemia-reperfusion injury
Data indicate that adenosine and CGS21680 upregulate CD39 and CD73 via E2F-1 (show E2F1 Antibodies) and CREB (show CREB1 Antibodies).
Acute cigarette smoke exposure induced CD39 upregulation in murine lungs and BALF cells. CD39 inhibition and deficiency led to augmented lung inflammation.
T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1 (show ARG1 Antibodies).
CD39 role in neuroinflammation: CD39 defines regulatory phenotypes in CD4 (show CD4 Antibodies)-positive T cells.
data suggest that CD39 expression in liver allografts modulates tissue injury
these data establish CD39 as a regionalized regulator of atherogenesis that is driven by shear stress.
CD39 and CD73 and their enzymatic activities that convert extracellular nucleotides are highly expressed and could have special function in the valve
Canalicular ectonucleoside NTPDase responsible for the main hepatic NTPDase activity. Ectonucleoside ATPases catalyze the hydrolysis of gamma- and beta-phosphate residues of nucleotides, playing a central role in concentration of extracellular nucleotides.
, NTPDase 8
, ectonucleoside triphosphate diphosphohydrolase 1
, liver ecto-ATP diphosphohydrolase
, CD39 antigen
, NTPDase 1
, ecto-ATP diphosphohydrolase 1
, ecto-ATPDase 1
, ecto-ATPase 1
, lymphoid cell activation antigen